123 related articles for article (PubMed ID: 15808143)
1. Intravenous cyclophosphamide in refractory polyneuropathy associated with IgM monoclonal gammopathy: an uncontrolled open trial.
Hamidou MA; Belizna C; Wiertlewsky S; Audrain M; Biron C; Grolleau JY; Mussini JM
Am J Med; 2005 Apr; 118(4):426-30. PubMed ID: 15808143
[No Abstract] [Full Text] [Related]
2. Intermittent cyclophosphamide with prednisone versus placebo for polyneuropathy with IgM monoclonal gammopathy.
Niermeijer JM; Eurelings M; van der Linden MW; Lokhorst HM; Franssen H; Fischer K; Teunissen LL; van den Berg LH; Schobben F; Wokke JH; Notermans NC
Neurology; 2007 Jul; 69(1):50-9. PubMed ID: 17606880
[TBL] [Abstract][Full Text] [Related]
3. Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy.
Niermeijer JM; Eurelings M; Lokhorst H; Franssen H; Fijnheer R; Wokke JH; Notermans NC
Neurology; 2006 Dec; 67(11):2076-9. PubMed ID: 17159126
[TBL] [Abstract][Full Text] [Related]
4. [Polyneuropathies and dysglobulinemias].
Ferrer S; Jiménez C
Rev Med Chil; 1994 Apr; 122(4):448-53. PubMed ID: 7809541
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin gene analysis in polyneuropathy associated with IgM monoclonal gammopathy.
Eurelings M; Notermans NC; Lokhorst HM; van Kessel B; Jacobs BC; Wokke JH; Sahota SS; Bloem AC
J Neuroimmunol; 2006 Jun; 175(1-2):152-9. PubMed ID: 16600385
[TBL] [Abstract][Full Text] [Related]
6. Successful management of polyneuropathy associated with IgM gammopathy of undetermined significance with antibody-based immunoadsorption.
Toepfer M; Schroeder M; Müller-Felber W; Lochmüller H; Sitter T; Pongratz D; Schiffl H
Clin Nephrol; 2000 May; 53(5):404-7. PubMed ID: 11305816
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic aberrations in neuropathy associated with IgM monoclonal gammopathy.
Eurelings M; Lokhorst HM; Notermans NC; Krijtenburg PJ; Kessel Bv; Eleveld MJ; Bloem A; Wokke JH; Poot M; Buijs A
J Neurol Sci; 2007 Sep; 260(1-2):124-31. PubMed ID: 17543994
[TBL] [Abstract][Full Text] [Related]
8. [A case of IgM paraproteinemia and chronic polyneuropathy with serum antibody reacting with PO protein and myelin-associated glycoprotein].
Nomura K; Hamaguchi K; Hosokawa T; Saito T; Ogawa Y
Rinsho Shinkeigaku; 1988 Apr; 28(4):426-32. PubMed ID: 2463888
[No Abstract] [Full Text] [Related]
9. Length dependence in polyneuropathy associated with IgM gammopathy.
Franssen H; Notermans NC
Ann Neurol; 2006 Feb; 59(2):365-71. PubMed ID: 16437567
[TBL] [Abstract][Full Text] [Related]
10. Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance.
Notermans NC; Lokhorst HM; Franssen H; Van der Graaf Y; Teunissen LL; Jennekens FG; Van den Berg LH; Wokke JH
Neurology; 1996 Nov; 47(5):1227-33. PubMed ID: 8909434
[TBL] [Abstract][Full Text] [Related]
11. Classical and lectin complement pathway activity in polyneuropathy associated with IgM monoclonal gammopathy.
Stork AC; Cats EA; Vlam L; Heezius E; Rooijakkers S; Herpers B; de Jong BA; Rijkers G; van Strijp J; Notermans NC; van den Berg LH; van der Pol WL
J Neuroimmunol; 2016 Jan; 290():76-9. PubMed ID: 26711574
[TBL] [Abstract][Full Text] [Related]
12. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
Kuijf ML; Eurelings M; Tio-Gillen AP; van Doorn PA; van den Berg LH; Hooijkaas H; Stork J; Notermans NC; Jacobs BC
Neurology; 2009 Sep; 73(9):688-95. PubMed ID: 19720975
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation in polyneuropathy associated with monoclonal gammopathy.
Eurelings M; Lokhorst HM; Kalmijn S; Wokke JH; Notermans NC
Neurology; 2005 Jun; 64(12):2079-84. PubMed ID: 15985576
[TBL] [Abstract][Full Text] [Related]
14. Treatment of cicatricial pemphigoid with pulse intravenous cyclophosphamide.
Musette P; Pascal F; Hoang-Xuan T; Heller M; Lok C; Deboise A; Dubertret L; Prost C
Arch Dermatol; 2001 Jan; 137(1):101-2. PubMed ID: 11176680
[No Abstract] [Full Text] [Related]
15. Prevalence of hepatitis C virus infection in IgM-type monoclonal gammopathy of uncertain significance and Waldenström macroglobulinemia.
Veneri D; Aqel H; Franchini M; Meneghini V; Krampera M
Am J Hematol; 2004 Dec; 77(4):421. PubMed ID: 15551289
[No Abstract] [Full Text] [Related]
16. Central nervous system involvement in patients with monoclonal gammopathy and polyneuropathy.
Lehmann HC; Hoffmann FR; Meyer Zu Hörste G; Hartung HP; Kieseier BC
Eur J Neurol; 2010 Aug; 17(8):1075-81. PubMed ID: 20236302
[TBL] [Abstract][Full Text] [Related]
17. Rituximab for polyneuropathy with IgM monoclonal gammopathy.
Niermeijer JM; Eurelings M; Lokhorst HL; van der Pol WL; Franssen H; Wokke JH; Notermans NC
J Neurol Neurosurg Psychiatry; 2009 Sep; 80(9):1036-9. PubMed ID: 19684235
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide-dexamethasone pulsed therapy for treatment of recalcitrant necrobiotic xanthogranuloma with paraproteinemia and ocular involvement.
Meyer S; Szeimies RM; Landthaler M; Hohenleutner S
Br J Dermatol; 2005 Aug; 153(2):443-5. PubMed ID: 16086766
[No Abstract] [Full Text] [Related]
19. Long-term effect of rituximab in anti-mag polyneuropathy.
Benedetti L; Briani C; Franciotta D; Carpo M; Padua L; Zara G; Zambello R; Sormani MP; Mancardi GL; Nobile-Orazio E; Schenone A
Neurology; 2008 Nov; 71(21):1742-4. PubMed ID: 19015493
[No Abstract] [Full Text] [Related]
20. Three families with polyneuropathy associated with monoclonal gammopathy.
Manschot SM; Notermans NC; van den Berg LH; Verschuuren JJ; Lokhorst HM
Arch Neurol; 2000 May; 57(5):740-2. PubMed ID: 10815142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
